The role of platelet-to-lymphocyte ratio in saphenous vein graft disease

References (5)

1. Kundi H, Balun A, Çiçekçioğlu H, Çetin M, Kızıltunç E, Çetin ZG, et al. Association between platelet-to-lymphocyte ratio and saphenous vein graft disease in patients with stable angina pectoris. Anatol J Cardiol 2015 May 5. Epub ahead of print
2. Botman CJ, Schonberger J, Koolen S, Penn O, Botman H, Dib N, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg 2007; 83: 2093-7
3. Yüksel M, Yıldız A, Oylumlu M, Akyüz A, Aydın M, Kaya H, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol 2015; 15: 640-7
4. Ryder E, Diez-Ewald M, Mosquera J, Fernández E, Pedreañez A, Vargas R, et al. Association of obesity with leukocyte count in obese individuals without metabolic syndrome. Diabetes Metab Syndr 2014;8:197-204
5. Demirçelik B, Çakmak M, Nazlı Y, Gürel OM, Akkaya N, Çetin M, et al. Adropin: A new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting. Clin Invest Med 2014; 37: 338-44.